Precise druggability of the PTH type 1 receptor.

Area of Science:

• Biochemistry
• Pharmacology
• Computational Biology

Background:

• Class B G protein-coupled receptors (GPCRs) possess large, deep binding pockets, hindering small molecule drug development.
• The parathyroid hormone type 1 receptor (PTHR) is a prototypic Class B GPCR, presenting significant therapeutic targeting challenges.

Purpose of the Study:

• To address the druggability of Class B GPCRs, using PTHR as a model.
• To identify novel allosteric modulators with biased signaling properties for PTHR.

Main Methods:

• Employed molecular dynamics simulations and elastic network model-based methods.
• Utilized a computational pipeline to detect druggable allosteric sites.
• Screened for small molecules targeting identified mechanical sites on PTHR.

Main Results:

• Identified a key mechanical site modulating PTHR collective dynamics.
• Discovered selective small molecules exhibiting negative allosteric modulation.
• Demonstrated biased PTHR signaling in cellular assays and PTH actions in vivo.

Conclusions:

• The developed computational pipeline effectively identifies druggable sites on Class B GPCRs.
• This strategy enables the discovery of allosteric modulators for PTHR signaling.
• The approach can be extended to other GPCRs for novel therapeutic candidate discovery.